Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)Fuyuhiko Motoi, Junji Furuse, Yutaka Matsuyama et al.|Japanese Journal of Clinical Oncology|2018Cited by 534
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo GuidelinesYasutoshi Kimura, Thomas R. Gadacz, Tadahiro Takada et al.|Journal of Hepato-Biliary-Pancreatic Surgery|2007Cited by 489
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trialChigusa Morizane, Junji Furuse, Takuji Okusaka et al.|Annals of Oncology|2019Cited by 333
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English editionMasaru Miyazaki, Tadahiro Takada, Hideyuki Yoshitomi et al.|Journal of Hepato-Biliary-Pancreatic Sciences|2015Cited by 300
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo GuidelinesKeita Wada, Myung‐Hwan Kim, Tadahiro Takada et al.|Journal of Hepato-Biliary-Pancreatic Surgery|2007Cited by 255